✦ LIBER ✦

(695): A 14-week, randomized, double-blind, placebo-controlled, monotherapy trial of pregabalin (BID) in patients with fibromyalgia syndrome (FMS)

✍ Scribed by L. Arnold; I. Russell; W. Duan; E. Diri; J. Young; S. Martin; U. Sharma; G. Haig; T. Griesing

Book ID: 119307486
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 40 KB
Volume: 8
Category: Article
ISSN: 1528-8447
DOI: 10.1016/j.jpain.2007.02.099

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 14-week, Randomized, Double-Blinded, P

A 14-week, Randomized, Double-Blinded, Placebo-Controlled Monotherapy Trial of Pregabalin in Patients With Fibromyalgia

✍ Lesley M. Arnold; I. Jon Russell; E.W. Diri; W. Rachel Duan; James P. Young Jr; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 533 KB

Safety and efficacy of esreboxetine in p

Safety and efficacy of esreboxetine in patients with fibromyalgia: A fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial

✍ Lesley M. Arnold; Ian Hirsch; Paul Sanders; Amanda Ellis; Bernadette Hughes 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

A randomized, double-blind, multicenter,

A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia

✍ Hiroyoshi Ohta, Hiroshi Oka, Chie Usui, Masayuki Ohkura, Makoto Suzuki, Kusuki N 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 370 KB

Efficacy and safety of pregabalin for tr

Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial

✍ J. Satoh; S. Yagihashi; M. Baba; M. Suzuki; A. Arakawa; T. Yoshiyama; S. Shoji 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Pregabalin in patients with central neur

Pregabalin in patients with central neuropathic pain: A randomized, double-blind, placebo-controlled trial of a flexible-dose regimen

✍ J.H. Vranken; M.G.W. Dijkgraaf; M.R. Kruis; M.H. van der Vegt; M.W. Hollmann; M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 126 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications

✍ Andrew J. Holman; Robin R. Myers 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 1 views

## Abstract ## Objective To assess the efficacy and safety of pramipexole, a dopamine 3 receptor agonist, in patients with fibromyalgia. ## Methods In this 14‐week, single‐center, double‐blind, placebo‐controlled, parallel‐group, escalating‐dose trial, 60 patients with fibromyalgia were randomiz